Related references
Note: Only part of the references are listed.Organizational culture affecting quality of care: guideline adherence in perioperative antibiotic use
Naoto Ukawa et al.
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE (2015)
Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma
Maria Angela Samis Zella et al.
ACTA NEUROCHIRURGICA (2014)
Temporal relationship of post-operative radiotherapy with temozolomide and oncologic outcome for glioblastoma
Daniel E. Spratt et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma
Kaisorn L. Chaichana et al.
NEURO-ONCOLOGY (2014)
Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma
Kaisorn L. Chaichana et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
RETROSPECTIVE COMPARISON OF CHEMORADIOTHERAPY FOLLOWED BY ADJUVANT CHEMOTHERAPY, WITH OR WITHOUT PRIOR GLIADEL IMPLANTATION (CARMUSTINE) AFTER INITIAL SURGERY IN PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMAS
Georges Noel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
The efficacy of carmustine wafers for older patients with glioblastoma multiforme: prolonging survival
Kaisorn L. Chaichana et al.
NEUROLOGICAL RESEARCH (2011)
The Risk of Getting Worse: Surgically Acquired Deficits, Perioperative Complications, and Functional Outcomes After Primary Resection of Glioblastoma
Sasha Gulati et al.
WORLD NEUROSURGERY (2011)
Persistent outpatient hyperglycemia is independently associated with survival, recurrence and malignant degeneration following surgery for hemispheric low grade gliomas
Kaisorn L. Chaichana et al.
NEUROLOGICAL RESEARCH (2010)
First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience
Hans Christoph Bock et al.
NEUROSURGICAL REVIEW (2010)
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme
Matthew J. McGirt et al.
JOURNAL OF NEUROSURGERY (2009)
Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience
Michael Sabel et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Factors related to surgical complications and their impact on the functional status in 236 open surgeries for malignant tumors in a Latinoamerican hospital
Alejandra T. Rabadan et al.
SURGICAL NEUROLOGY (2007)
Risk factors for neurosurgical site infections after craniotomy: a critical reappraisal of antibiotic prophylaxis on 4578 patients
AM Korinek et al.
BRITISH JOURNAL OF NEUROSURGERY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project
SM Chang et al.
JOURNAL OF NEUROSURGERY (2003)
Risk factors for postcraniotomy surgical site infection after 1,3-bis(2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement
PC McGovern et al.
CLINICAL INFECTIOUS DISEASES (2003)
Factors influencing surgical complications of intra-axial brain tumours
M Brell et al.
ACTA NEUROCHIRURGICA (2000)
Share Paper
